The WHO recommended rabies vaccines include three types: human diploid cell rabies vaccine, primary cell culture vaccine and Vero cell rabies vaccine.
1. Human diploid cell rabies vaccine: this is the first purified, concentrated, adjuvant-free freeze-dried vaccine, which is safer, with fewer adverse reactions and better safety and stability, but it is expensive and requires multiple inoculations to produce antibodies, so it is not much used in clinical practice.
2. Primary cell culture vaccine: it can be used to prevent rabies virus, and was once widely used, but there are certain contraindications and adaptive groups, not all people can be vaccinated, and it is more restricted, and not much used in the clinic.
3. Vero cell rabies vaccine: this is our more common rabies virus vaccine, clinically used more frequently, with high safety, small side effects and strong immunity characteristics.
In addition, at present, rabies is still an incurable disease, so once there is a rabies exposure, must be timely treatment of wounds, and actively inoculated with rabies vaccine.